[1] Chu SL, Tong ZH, Zhang YT, Ye XW, Liu ZY, Chen H, et al. Usage, acceptability, and preliminary effectiveness of an mHealth-based integrated modality for smoking cessation interventions in Western China. Tob Induc Dis 2023;21:7. http://dx.doi.org/10.18332/tid/156828CrossRef
[2] Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011;6:42. http://dx.doi.org/10.1186/1748-5908-6-42CrossRef
[3] Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992;28:183-218. https://pubmed.ncbi.nlm.nih.gov/1620663/.https://pubmed.ncbi.nlm.nih.gov/1620663/
[4] Bronfenbrenner U. The ecology of human development: experiments by nature and design. Cambridge: Harvard University Press, 1979. https://www.jstor.org/stable/j.ctv26071r6.https://www.jstor.org/stable/j.ctv26071r6
[5] U.S. Department of Health and Human Services. Smoking cessation: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020. https://www.cdc.gov/tobacco/data_statistics/sgr/2020-smoking-cessation/pdfs/2020-cessation-sgr-front-matter-508c.pdf.https://www.cdc.gov/tobacco/data_statistics/sgr/2020-smoking-cessation/pdfs/2020-cessation-sgr-front-matter-508c.pdf
[6] Michie S, Hyder N, Walia A, West R. Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011;36(4):315 − 9. http://dx.doi.org/10.1016/j.addbeh.2010.11.016CrossRef
[7] Chu SL, Feng LT, Zuo Y, Jing H, Zhang D, Tong ZH, et al. Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial. BMC Public Health 2023;23(1):561. http://dx.doi.org/10.1186/s12889-023-15448-7CrossRef
[8] Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5(1):13-25. https://pubmed.ncbi.nlm.nih.gov/12745503/.https://pubmed.ncbi.nlm.nih.gov/12745503/
[9] Nan Y, Wang LL, Wang JJ, Jiang Y, Yang Y. Effectiveness evaluation on quitline services in four Chinese cities. Chin J Health Educ 2015;31(3):256 − 8. http://dx.doi.org/10.16168/j.cnki.issn.1002-9982.2015.03.004 (In Chinese). CrossRef
[10] Jiang B, He Y, Zuo F, Wu L, Liu QH, Zhang L, et al. Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China. BMJ Open 2016;6(1):e009381. http://dx.doi.org/10.1136/bmjopen-2015-009381CrossRef